In this issue:
- Is RA always preceded by a symptomatic phase of arthralgia?
- CV outcomes with low-dose glucocorticoids in RA
- Physical inactivity exacerbates inflammatory signalling in systemic lupus
- Impact of patient characteristics on disease activity cutoffs in axial SpA
- Effect of sex and age on biologic DMARD efficacy in axial SpA
- Escalation to second-line therapies in early RA: risk of becoming difficult-to-treat
- JAK inhibitors in difficult-to-treat RA
- CV safety of JAK inhibitors in RA
- RA and ischaemic stroke risk after AF
- Systemic JIA and adult-onset Still’s disease: the same disease
Please login below to download this issue (PDF)